Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | BRD2 | P25440 | 1/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.38 |
| ▸ | PER2 | O15055 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14684654 | 0.94 | PER2 (0.39) | BRD4BRD2PIK3CDPER2LMNA | |
| SCHEMBL19918851 | 0.92 | SMN1; SMN2 (0.40) | BRD4BRD2PIK3CDPER2LMNA | |
| SCHEMBL22081453 | 0.85 | BRD4 (0.36) | BRD4BRD2PIK3CDPER2LMNA | |
| SCHEMBL19918791 | 0.84 | BRD4 (0.39) | BRD4BRD2PIK3CDPER2LMNA | |
| SCHEMBL3656227 | 0.83 | BRD4 (0.41) | BRD4BRD2PIK3CDPER2LMNA | |
| SCHEMBL14459653 | 0.83 | BRD4 (0.41) | BRD4BRD2PIK3CDPER2LMNA | |
| SCHEMBL6606439 | 0.82 | BRD4 (0.40) | BRD4BRD2PIK3CDPER2LMNA | |
| SCHEMBL21465976 | 0.82 | BRD4 (0.40) | BRD4BRD2PIK3CDPER2LMNA | |
| SCHEMBL11028251 | 0.82 | BRD4 (0.40) | BRD4BRD2PIK3CDPER2LMNA | |
| SCHEMBL4508963 | 0.82 | BRD4 (0.40) | BRD4BRD2PIK3CDPER2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112076769-A | Spherical bismuth vanadate/black phosphorus composite photocatalyst and preparation method thereof | 大连民族大学 | 2020-12-15 | — | — | CN | claimed |
| US-20240226107-A1 | UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) INHIBITOR | HAINAN SIMCERE ZAIMING PHARMACEUTICAL CO., LTD. (CN) | 2024-07-11 | — | — | US | disclosed |
| US-20240189763-A1 | CONTAMINANT REMOVAL PROCESS | TAMINCO BV (BE) | 2024-06-13 | — | — | US | disclosed |
| US-11820781-B2 | Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway | NURIX THERAPEUTICS, INC. (US) | 2023-11-21 | — | — | US | disclosed |
| US-20230331657-A1 | NANOMATERIALS COMPRISING ESTER-LINKED ACETALS | BEAM THERAPEUTICS INC. | 2023-10-19 | — | — | US | disclosed |
| US-20230312556-A1 | ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) | 2023-10-05 | — | — | US | disclosed |
| US-20230203491-A1 | DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR TREATING COVID-19 CONTAINING SAME | SIRNAGEN THERAPEUTICS CORPORATION (KR) | 2023-06-29 | — | — | US | disclosed |
| EP-3768775-B1 | POLYOLEFIN AND POLYVINYLPYRROLIDONE FORMULATION | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-06-07 | — | — | EP | disclosed |
| US-20230150254-A1 | ON-PRESS DEVELOPMENT TYPE LITHOGRAPHIC PRINTING PLATE PRECURSOR, METHOD OF PREPARING LITHOGRAPHIC PRINTING PLATE, AND LITHOGRAPHIC PRINTING METHOD | FUJIFILM CORPORATION (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20230047209-A1 | PYRIDO-PYRIMIDINONE AND PTERIDINONE COMPOUNDS AND METHODS OF USE | PARAZA PHARMA, INC. (CA) | 2023-02-16 | — | — | US | disclosed |
| US-20140255846-A1 | POLYMERIZABLE COMPOSITION, AND PHOTOSENSITIVE LAYER, PERMANENT PATTERN, WAFER-LEVEL LENS, SOLID-STATE IMAGING DEVICE AND PATTERN FORMING METHOD EACH USING THE COMPOSITION | FUJIFILM CORPORATION (JP) | 2014-09-11 | — | — | US | disclosed |
| US-8790852-B2 | Colored composition for light-shielding film, light-shielding pattern, method for forming the same, solid-state image sensing device, and method for producing the same | FUJIFILM CORPORATION (JP) | 2014-07-29 | — | — | US | disclosed |
| US-8728712-B2 | Polymerizable composition | FUJIFILM CORPORATION (JP) | 2014-05-20 | — | — | US | disclosed |
| US-20130143164-A1 | POLYMERIZABLE COMPOSITION | FUJIFILM CORPORATION (JP) | 2013-06-06 | — | — | US | disclosed |
| US-20120257283-A1 | DISPERSION COMPOSITION, PHOTOSENSITIVE RESIN COMPOSITION, AND SOLID-STATE IMAGE PICK-UP ELEMENT | FUJIFILM CORPORATION (JP) | 2012-10-11 | — | — | US | disclosed |
| US-8278386-B2 | Dispersion composition, polymerizable composition, light-shielding color filter, solid-state image pick-up element, liquid crystal display device, wafer level lens, and image pick-up unit | FUJIFILM CORPORATION (JP) | 2012-10-02 | — | — | US | disclosed |
| US-20120104529-A1 | COLORED COMPOSITION FOR LIGHT-SHIELDING FILM, LIGHT-SHIELDING PATTERN, METHOD FOR FORMING THE SAME, SOLID-STATE IMAGE SENSING DEVICE, AND METHOD FOR PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2012-05-03 | — | — | US | disclosed |
| US-20110217637-A1 | POLYMERIZABLE COMPOSITION FOR COLOR FILTER, COLOR FILTER, AND SOLID-STATE IMAGING DEVICE | FUJIFILM CORPORATION (JP) | 2011-09-08 | — | — | US | disclosed |
| US-20110124824-A1 | DISPERSION COMPOSITION, POLYMERIZABLE COMPOSITION, LIGHT-SHIELDING COLOR FILTER, SOLID-STATE IMAGE PICK-UP ELEMENT, LIQUID CRYSTAL DISPLAY DEVICE, WAFER LEVEL LENS, AND IMAGE PICK-UP UNIT | FUJIFILM CORPORATION (JP) | 2011-05-26 | — | — | US | disclosed |
| US-20090293748-A1 | PLATEMAKING METHOD FOR LITHOGRAPHIC PRINTING PLATE PRECURSOR AND PLANOGRAPHIC PRINTING METHOD | MITSUMOTO TOMOYOSHI | 2009-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203491-A1 | DOUBLE-STRANDED OLIGONUCLEOTIDE AND COMPOSITION FOR TREATING COVID-19 CONTAINING SAME | ACE2, POLRMT, POLN | BRD4 1298/4885BRD2 1184/4885PIK3CD 3648/4885 |
| US-20240226107-A1 | UBIQUITIN-SPECIFIC PROTEASE 1 (USP1) INHIBITOR | USP1, USP2, USP3 | BRD4 1342/4885BRD2 1551/4885PIK3CD 3403/4885 |
| US-20230047209-A1 | PYRIDO-PYRIMIDINONE AND PTERIDINONE COMPOUNDS AND METHODS OF USE | TYMP, TYMS, DPYD | BRD4 641/4885BRD2 1555/4885PIK3CD 906/4885 |
| US-11820781-B2 | Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway | BTK, CBL, XIAP | BRD4 562/4885BRD2 364/4885PIK3CD 233/4885 |
| US-20230331657-A1 | NANOMATERIALS COMPRISING ESTER-LINKED ACETALS | LIPA, SGMS1, SGMS2 | BRD4 3921/4885BRD2 3382/4885PIK3CD 779/4885 |
| US-20230312556-A1 | ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF | AHR, ARNT, NOTUM | BRD4 1329/4885BRD2 1661/4885PIK3CD 1980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.